PREVALENCE OF OSTEOPENIA, OSTEOPOROSIS, AND ASSOCIATED FACTORS AMONG WOMEN AGED 40-60 YEARS WORKING AT THONG NHAT HOSPITAL IN 2025

Quoc Cuong TRAN1, Quoc Nam` HOANG, Thao Trang NGUYEN PHAM2, , Hoang Lan Phuong NGUYEN, Thi Minh Nguyet TRAN, Thi Phuong Lan TRAN, Bao Lien CONG HUYEN TON NU
1 Trường Đại học Y khoa Phạm Ngọc Thạch
2 Bệnh viện Thống Nhất

Main Article Content

Abstract

Aims: To determine the prevalence of osteopenia and osteoporosis and to identify associated factors among women aged 40-60 years working at Thong Nhat Hospital.

Methods: A cross-sectional study was conducted among 131 women aged 40-60 years. Anthropometric measurements were obtained, bone mineral density (BMD) was measured by dual-energy X-ray absorptiometry (Hologic model Discovery Wi), and serum vitamin D concentrations were determined. Menopausal status was assessed through interviews. Osteopenia was defined as a T-score ≤ −1.0 at either total lumbar spine, total femoral or femoral neck, while osteoporosis was defined as a T-score ≤ −2.5 at either site.

Results: The prevalence of osteopenia and osteoporosis was 39,7% (95% CI: 31,7–48,3) and 6,1% (95% CI: 3,1–11,6), respectively. The overall prevalence of low bone mineral density was 45,8% (95% CI: 37,5–54,3). Obesity was present in 18,3% of participants, and 96,2% had serum 25-OH vitamin D levels below 30 ng/mL. In the multivariable model, age was independently associated with osteoporosis after adjustment for BMI. For every 5-year increase in age, the odds of osteoporosis increased 7,71-fold (OR = 7,71; 95% CI: 2,40–43,68; p < 0,001).

Conclusions: Low bone density and vitamin D insufficiency/deficiency are common among women aged 40-60 years in Thong Nhat Hospital. Age was independently associated with osteoporosis.

Article Details

References

1. Digital Science & Research Solutions, Inc. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993; 94(6): 646–650. doi:10.1016/0002-9343(93)90218-e.
2. Harvey N, Dennison E, Cooper C. Osteoporosis: impact on health and economics. Nat Rev Rheumatol. 2010; 6(2): 99–105. Doi: 10.1038/nrrheum.2009.260
3. Salari N, Ghasemi H, Mohammadi L, Behzadi MH, et al. The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. 2021 Oct 17;16(1):609. doi: 10.1186/s13018-021-02772-0.
4. Hoang DK, Doan MC, Mai LD, Ho-Le TP, Ho-Pham LT. Burden of osteoporosis in Vietnam: An analysis of population risk. PloS one. 2021;16(6):e0252592. doi: 10.1371/journal.pone.0252592
5. Sözen T, Özışık L, Başaran NÇ. An Overview and Management of Osteoporosis Eur. J. Rheumatol. 2017;4:46–56. doi:10.5152/eurjrheum.2016.048.
6. Lại Thị Thùy Dương. Nghiên cứu thực trạng loãng xương ở phụ nữ sau mãn kinh đến khám tại khoa khám bệnh theo yêu cầu Bệnh viện Bạch Mai. Tạp chí Y học Việt Nam. 15/9/2023. 530(1):199-204. doi: 10.51298/vmj.v530i1.6603
7. Ho-Pham LT, Nguyen HG, Nguyen-Pham SQ, Hoang DK, Tran TS, Nguyen TV. Longitudinal changes in bone mineral density during perimenopausal transition:the Vietnam Osteoporosis Study. Osteoporos Int. 2023 Aug;34(8):1381-1387. doi: 10.1007/s00198-023-06757-z.
8. Shariati-Sarabi Z, Rezaie HE, Milani N, Rezaie FE, Rezaie AE. Evaluation of Bone Mineral Density in Perimenopausal Period. Arch Bone Jt Surg. 2018 Jan;6(1):57-62. PMID: 29430497; PMCID: PMC5799602..
9. Hồ Phạm Thục Lan, Phạm Ngọc Hoa, Lại Quốc Thái, Nguyễn Dạ Thảo Uyên, Nguyễn Đình Nguyên, Nguyễn Văn Tuấn. Chẩn đoán loãng xương: ảnh hưởng của giá trị tham chiếu. Thời sự Y học TP Hồ Chí Minh. 2011: 57(1&2):1-10. [trích dẫn 20/8/2026 ]. Có sẵn tại: http://hoiyhoctphcm.org.vn/chan-doan-loang-xuong-anh-huong-cua-gia-tri-tham-chieu/
10. World Health Organization, Regional Office for the Western Pacific; International Association for the Study of Obesity; International Obesity Task Force. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney: Health Communications Australia; 2000).
11. Bộ Y tế. Hướng dẫn chẩn đoán và điều trị các bệnh cơ xương khớp. 2014.
12. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab.2011;96:1911–30. https://doi.org/10.1210/jc.2011-0385
13. Smeets-Goevaers CG, Lesusink GL, Papapoulos SE, Maartens LW, Keyzer JJ, et al. The prevalence of low bone mineral density in Dutch perimenopausal women: the Eindhoven perimenopausal osteoporosis study. Osteoporos Int. 1998;8(5):404-9. doi: 10.1007/s001980050083.
14. Bouillon R, Marcocci C, Carmeliet G, Bikle D, White JH, et al. Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions. Endocr Rev. 2019;40:1109–51. https://doi.org/10.1210/er.2018-00126
15. Pilz S, März W, Cashman KD, Kiely ME, Whiting SJ, Holick MF, et al. Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper. Front Endocrinol.2018;9:373. https://doi.org/10.3389/fendo.2018.00373
16. Eastell R, O’Neill TW, Hofbauer LC, Langdahl B, Reid IR, et al. Postmenopausal osteoporosis. Nat Rev Dis Primer.2016;2:16069. https://doi.org/10.1038/nrdp.2016.69.